Abstract:Background: Memory and cognitive impairments/disorders are the main clinical symptoms of neurodegenerative diseases. The prevalence of such chronic conditions has increased over the past three decades. There is a growing interest in the use of food-derived bioactive products as intervention agents in functional foods and dietary supplements for the fights against these human diseases. Dietary bioactive peptides with neuroprotective and cognitive-enhancing effects are attracting increasing attention, owing to their abilities to influence cognition and mental health in vivo and in vitro. Scope and approach: This article reviews recent studies on neuroprotective peptides to gain insights into their potential food sources, industrially feasible production methods, and duration and mechanism(s) of action. Challenges associated with the comparison of the results from published studies employing different analysis methods, complexities of raw materials and in vivo or in vitro systems, diverse sequence-derived structural and physicochemical features, and structure-activity relationships for neuroprotective peptides are all critically discussed. Key findings and conclusions: The current review confirms the growing interest in searching natural, effective and affordable neuroprotective peptides or protein hydrolysates, and increasing knowledge about mechanisms underlying their brain health benefits and functions against cognitive impairments. Among the in vitro and in vivo methods used to characterize and verify neuroprotective peptides, bioinformatics and peptidomics approaches emerge as cost-effective screening methods. Previous published studies mainly focused on the effects of the production methods/processes of bioactive peptides on their chemical composition and neuroprotective functions. However, the structure-activity relationships of neuroprotective peptides as well as their underlying working mechanisms and molecular pathways in the prevention and treatment of cognitive deficits have received little attention. The findings presented in this review can be used to support the design and production of neuroprotective peptides acceptable by consumers.

Impact of Peptide Transport and Memory Function in the Brain

Effects of food-derived bioactive peptides on cognitive deficits and memory decline in neurodegenerative diseases: A review

Potential of Food-Derived Bioactive Peptides in Alleviation and Prevention of Alzheimer's Disease.

Food-Derived Peptides as Promising Neuroprotective Agents: Mechanism and Therapeutic Potential

Recent advances in delivery of peptide and protein therapeutics to the brain

Advanced Noninvasive Strategies for the Brain Delivery of Therapeutic Proteins and Peptides

Recent developments in peptide drug delivery to the brain

Bridging Neurotrophic Factors and Bioactive Peptides to Alzheimer's Disease.

Peptide-decorated Nanocarriers Penetrating the Blood-Brain Barrier for Imaging and Therapy of Brain Diseases.

Research progress on the protection and mechanism of active peptides in Alzheimer's disease and Parkinson's disease

A Supramolecular Protein Assembly Intrinsically Rescues Memory Deficits in an Alzheimer’s Disease Mouse Model

Neuropeptides as Potential Biomarkers in Vascular Dementia

Peptides crossing the blood-brain barrier: some unusual observations

Research progress on transport mechanism of amyloid beta-peptides across blood-brain barrier

Peripheral Administration of a Cell-Penetrating MOTS-c Analogue Enhances Memory and Attenuates Aβ1-42- or LPS-Induced Memory Impairment Through Inhibiting Neuroinflammation.

Local Delivery Strategies for Peptides and Proteins into the CNS: Status Quo, Challenges, and Future Perspectives

Brain Penetrating Peptides and Peptide–drug Conjugates to Overcome the Blood–brain Barrier and Target CNS Diseases

Application of Cationic Peptides in Treatment of Central Nervous System Disease

Peptides derived from growth factors: Exploring their diverse impact from antimicrobial properties to neuroprotection

Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges

Targeting Cerebral Diseases with Enhanced Delivery of Therapeutic Proteins Across the Blood-Brain Barrier